Abstract
Within the last few years a considerable amount of evaluative studies has been published that investigate the performance of 3D virtual screening approaches. Thereby, in particular assessments of protein–ligand docking are facing remarkable interest in the scientific community. However, comparing virtual screening approaches is a non-trivial task. Several publications, especially in the field of molecular docking, suffer from shortcomings that are likely to affect the significance of the results considerably. These quality issues often arise from poor study design, biasing, by using improper or inexpressive enrichment descriptors, and from errors in interpretation of the data output. In this review we analyze recent literature evaluating 3D virtual screening methods, with focus on molecular docking. We highlight problematic issues and provide guidelines on how to improve the quality of computational studies. Since 3D virtual screening protocols are in general assessed by their ability to discriminate between active and inactive compounds, we summarize the impact of the composition and preparation of test sets on the outcome of evaluations. Moreover, we investigate the significance of both classic enrichment parameters and advanced descriptors for the performance of 3D virtual screening methods. Furthermore, we review the significance and suitability of RMSD as a measure for the accuracy of protein–ligand docking algorithms and of conformational space sub sampling algorithms.
Similar content being viewed by others
References
Klebe G (2006) Drug Discovery Today 11:580–594
Schneider G, Bohm H-J (2002) Drug Discovery Today 7:64–70
Chen H, Lyne PD, Giordanetto F, Lovell T, Li J (2006) J Chem Inf Model 46:401–415
Cole JC, Murray CW, Nissink JWM, Taylor RD, Taylor R (2005) Proteins: Struct Funct Bioinf 60:325–332
Kontoyianni M, McClellan LM, Sokol GS (2004) J Med Chem 47:558–565
Steindl TM, Schuster D, Wolber G, Laggner C, Langer T (2006) J Comput Aided Mol Des 20:703–715
Steindl TM, Schuster D, Laggner C, Chuang K, Hoffmann RD, Langer T (2007) J Chem Inf Model 47:563–571
Steindl TM, Schuster D, Laggner C, Langer T (2006) J Chem Inf Model 46:2146–2157
Sheng C, Zhang W, Ji H, Zhang M, Song Y, Xu H, Zhu J, Miao Z, Jiang Q, Yao J, Zhou Y, Zhu J, Lue J (2006) J Med Chem 49:2512–2525
Güner OF (2000) Pharmacophore perception, development and use in drug design. International University Line, La Jolla, CA
Catalyst; Accelrys: San Diego, CA
Verdonk ML, Berdini V, Hartshorn MJ, Mooij WTM, Murray CW, Taylor RD, Watson P (2004) J Chem Inf Comput Sci 44:793–806
Weber L (2005) QSAR Comb Sci 24:809–823
Wolber G, Langer T (2000) 13th European symposium on quantitative structure-activity relationships, Duesseldorf, Germany, Aug 27 - Sept 1, 2000
Schueller A, Haehnke V, Schneider G (2007) QSAR Comb Sci 26:407–410
Huang N, Shoichet BK, Irwin JJ (2006) J Med Chem 49:6789–6801
Pan Y, Huang N, Cho S, MacKerell AD Jr (2003) J Chem Inf Comput Sci 43:267–272
Jones G, Willett P, Glen RC (1995) J Mol Biol 245:43–53
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727–748
Irwin JJ, Shoichet BK (2005) J Chem Inf Model 45:177–182
Edwards BS, Bologa C, Young SM, Balakin KV, Prossnitz ER, Savchuck NP, Sklar LA, Oprea TI (2005) Mol Pharmacol 68:1301–1310
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) Nucleic Acids Res 28:235–242
Wolber G, Langer T (2005) J Chem Inf Model 45:160–169
Miller MA (2002) Nat Rev Drug Discovery 1:220–227
Knox AJS, Meegan MJ, Carta G, Lloyd DG (2005) J Chem Inf Model 45:1908–1919
Moe; Chemical Computing Group: Montreal, QC, Canada
Pospisil P, Ballmer P, Scapozza L, Folkers G (2003) J Recept Signal Transduction 23:361–371
Oellien F, Cramer J, Beyer C, Ihlenfeldt W-D, Selzer PM (2006) J Chem Inf Comput Sci 46:2342–2354
Willett P, Barnard JM, Downs GM (1998) J Chem Inf Comput Sci 38:983–996
Flower DR (1998) J Chem Inf Comput Sci 38:379–386
Brandstetter H, Grams F, Glitz D, Lang A, Huber R, Bode W, Krell H-W, Engh RA (2001) J Biol Chem 276:17405–17412
Yan X, Hollis T, Svinth M, Day P, Monzingo AF, Milne GWA, Robertus JD (1997) J Mol Biol 266:1043–1049
Nederkoorn PHJ, Vernooijs P, Donne-Op den Kelder GM, Baerends EJ, Timmerman H (1994) J Mol Graph 12:242–256
Tautomer; Molecular Networks GmbH: Erlangen, Germany
Pospisil P, Ballmer P, Scapozza L, Folkers G (2004) 15th European symposium on Structure-Activity Relationships (QSAR) and molecular modelling, Istanbul, Turkey, Sept 5–10, 2004
Li J, Ehlers T, Sutter J, Varma-O’Brien S, Kirchmair J (2007) J Chem Inf Model 47:1923–1932
Kirchmair J, Laggner C, Wolber G, Langer T (2005) J Chem Inf Model 45:422–430
Kirchmair J, Wolber G, Laggner C, Langer T (2006) J Chem Inf Model 46:1848–1861
Onodera K, Satou K, Hirota H (2007) J Chem Inf Model 47:1609–1618
Corina; Molecular Networks GmbH: Erlangen, Germany
Carta G, Onnis V, Knox AJS, Fayne D, Lloyd DG (2006) J Comput Aided Mol Des 20:179–190
Stahl M, Rarey M (2001) J Med Chem 44:1035–1042
Clark RD, Strizhev A, Leonard JM, Blake JF, Matthew JB (2002) J Mol Graph Model 20:281–295
Charifson PS, Corkery JJ, Murcko MA, Walters WP (1999) J Med Chem 42:5100–5109
Schulz-Gasch T, Stahl M (2003) J Mol Mod 9:47–57
Warren GL, Andrews CW, Capelli A-M, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) J Med Chem 49:5912–5931
Kellenberger E, Rodrigo J, Muller P, Rognan D (2004) Proteins: Struct, Funct, Bioinf 57:225–242
Nissink JWM, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R (2002) Proteins: Struct, Funct, Genet 49:457–471
Goto J, Kataoka R, Hirayama N (2004) J Med Chem 47:6804–6811
Kristam R, Gillet VJ, Lewis RA, Thorner D (2005) J Chem Inf Model 45:461–476
Kramer B, Rarey M, Lengauer T (1999) Proteins 37:228–241
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Ewing TJA, Makino S, Skillman AG, Kuntz ID (2001) J Comput Aided Mol Des 15:411–428
Ewing TJA, Kuntz ID (1997) J Comput Chem 18:1175–1189
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) J Med Chem 47:1739–1749
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) J Med Chem 47:1750–1759
Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) J Mol Graph Model 21:289–307
Jain AN (2003) J Med Chem 46:499–511
McGann MR, Almond HR, Nicholls A, Grant JA, Brown FK (2003) Biopolymers 68:76–90
Kirchmair J, Ristic S, Eder K, Markt P, Wolber G, Laggner C, Langer T (2007) J Chem Inf Model 47:2182–2196
Teodoro ML, Kavraki LE (2003) Curr Pharm Des 9:1635–1648
Claussen H, Buning C, Rarey M, Lengauer T (2001) J Mol Biol 308:377–395
Murray CW, Baxter CA, Frenkel AD (1999) J Comput Aided Mol Des 13:547–562
Wang R, Wang S (2001) J Chem Inf Comput Sci 41:1422–1426
Terp GE, Johansen BN, Christensen IT, Jorgensen FS (2001) J Med Chem 44:2333–2343
Wang R, Lai L, Wang S (2002) J Comput Aided Mol Des 16:11–26
Zavodszky MI, Sanschagrin PC, Kuhn LA, Korde RS, Kuhn LA (2003) J Comput Aided Mol Des 16:883–902
Kroemer RT, Vulpetti A, McDonald JJ, Rohrer DC, Trosset J-Y, Giordanetto F, Cotesta S, McMartin C, Kihlen M, Stouten PFW (2004) J Chem Inf Comput Sci 44:871–881
Abagyan RA, Totrov MM (1997) J Mol Biol 268:678–685
Langer T, Hoffmann RD (2006) Pharmacophores and pharmacophore searches. Wiley-VCH, Weinheim
Triballeau N, Acher F, Brabet I, Pin J-P, Bertrand H-O (2005) J Med Chem 48:2534–2547
Truchon J-F, Bayly CI (2007) J Chem Inf Model 47:488–508
Jacobsson M, Liden P, Stjernschantz E, Bostroem H, Norinder U (2003) J Med Chem 46:5781–5789
Shepherd AJ, Gorse D, Thornton JM (1999) Protein Sci 8:1045–1055
Gao H, Williams C, Labute P, Bajorath J (1999) J Chem Inf Comput Sci 39:164–168
Martineau E, Aman AM, Kong X (2004) Accelrysworld. Accelrys, Inc., San Diego, CA
Guha R, Jurs Peter C (2005) J Chem Inf Model 45:65–73
Weston J, Perez-Cruz F, Bousquet O, Chapelle O, Elisseeff A, Schoelkopf B (2003) Bioinformatics 19:764–771
Ford MG (2003) 2nd international symposium on computational methods in toxicology and pharmacology integrating internet resources, Thessaloniki, Greece, 2003
Bradley EK, Miller JL, Saiah E, Grootenhuis PDJ (2003) J Med Chem 46:4360–4364
Bradley EK, Beroza P, Penzotti JE, Grootenhuis PDJ, Spellmeyer DC, Miller JL (2000) J Med Chem 43:2770–2774
Matthews BW (1975) Biochim Biophys Acta 405:442–451
Frimurer TM, Bywater R, Nrum L, Lauritsen LN, Brunak S (2000) J Chem Inf Comput Sci 40:1315–1324
Hecker EA, Duraiswami C, Andrea TA, Diller DJ (2002) J Chem Inf Comput Sci 42:1204–1211
Diller DJ, Li R (2003) J Med Chem 46:4638–4647
Diller DJ, Merz KM Jr (2001) Proteins: Struct, Funct, Genet 43:113–124
Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) J Med Chem 48:2534–2547
Sheridan RP, Singh SB, Fluder EM, Kearsley SK (2001) J Chem Inf Comput Sci 41:1395–1406
Park SH, Goo JM, Jo CH (2004) Korean J Radiol 5:11–18
McGaughey GB, Sheridan RP, Bayly CI, Culberson JC, Kreatsoulas C, Lindsley S, Maiorov V, Truchon J-F, Cornell WD (2007) J Chem Inf Model 47:1504–1519
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirchmair, J., Markt, P., Distinto, S. et al. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes?. J Comput Aided Mol Des 22, 213–228 (2008). https://doi.org/10.1007/s10822-007-9163-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9163-6